Glaxosmithkline Biologicals Kft.
Plant certified by the Brazilian health regulator (ANVISA)
ANVISA, the Brazilian health regulator, holds a valid Good Manufacturing Practice certificate for this plant, covering biological active pharmaceutical ingredients, valid until 2028-11-11. The certificate is issued after an inspection of the plant itself, which is why a foreign regulator names this site: goods made here are allowed on the Brazilian market. Process number 25351187966201821.
- Type
- Manufacturer
- Location
- Hungary
- Categories
- Fabricação farmacêutica
- Markets
- Hungria, Brasil
Listed in a source registry
Verified facts
- gmp-certified (green), checked 2026-08-21 ANVISA (Brazilian Health Regulatory Agency), public register of Good Manufacturing Practice certificates (CBPF)
- registered-manufacturer (green), checked 2026-08-21 Jordan Food and Drug Administration (JFDA), approved manufacturing sites (open data portal of Jordan)
- lei-active (green), checked 2026-08-23 GLEIF global LEI register (golden copy)
Import rules for these goods
- Medicines imported into the EU must come from a site holding an EU GMP certificate, and the importer needs a manufacturing/import authorisation. European Medicines Agency (GMP)